Tango Therapeutics (TNGX) Other Gross PP&E Adjustments (2020 - 2025)
Tango Therapeutics (TNGX) has 6 years of Other Gross PP&E Adjustments data on record, last reported at -$18.2 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 21.02% year-over-year to -$18.2 million; the TTM value through Dec 2025 reached -$18.2 million, up 21.02%, while the annual FY2025 figure was -$18.2 million, 21.02% up from the prior year.
- Other Gross PP&E Adjustments reached -$18.2 million in Q4 2025 per TNGX's latest filing, up from -$19.2 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $11.0 million in Q2 2022 and bottomed at -$33.3 million in Q3 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$18.6 million, with a median of -$23.6 million recorded in 2024.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 401.69% in 2021, then plummeted 11492.81% in 2022.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $6.1 million in 2021, then tumbled by 629.47% to -$32.3 million in 2022, then increased by 14.63% to -$27.6 million in 2023, then increased by 16.55% to -$23.0 million in 2024, then grew by 21.02% to -$18.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$18.2 million in Q4 2025, -$19.2 million in Q3 2025, and -$20.2 million in Q2 2025.